Comparative Pharmacology
Head-to-head clinical analysis: ZOFRAN AND DEXTROSE IN PLASTIC CONTAINER versus ZOFRAN PRESERVATIVE FREE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: ZOFRAN AND DEXTROSE IN PLASTIC CONTAINER versus ZOFRAN PRESERVATIVE FREE.
ZOFRAN AND DEXTROSE IN PLASTIC CONTAINER vs ZOFRAN PRESERVATIVE FREE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Ondansetron is a selective serotonin 5-HT3 receptor antagonist. It blocks the action of serotonin at 5-HT3 receptors in the chemoreceptor trigger zone (CTZ) and gastrointestinal tract, thereby preventing nausea and vomiting. Dextrose provides caloric support.
Selective 5-HT3 receptor antagonist; blocks serotonin binding at 5-HT3 receptors in the chemoreceptor trigger zone (CTZ) and gastrointestinal tract, inhibiting emetic reflex.
4 mg IV or IM every 8 hours as needed; for prevention of chemotherapy-induced nausea and vomiting, 0.15 mg/kg IV up to 16 mg per dose, infused over 15 minutes, given 30 minutes before chemotherapy, then repeat at 4 and 8 hours after first dose, or as a single 32 mg IV dose over 15 minutes immediately before chemotherapy.
4-8 mg intravenously or intramuscularly as a single dose for prevention of chemotherapy-induced nausea and vomiting; 8 mg orally 30 minutes before chemotherapy, repeated every 8-12 hours as needed.
None Documented
None Documented
Terminal elimination half-life is approximately 3–4 hours in adults, though may be prolonged to 5–8 hours in severe hepatic impairment (Child-Pugh class C) or elderly patients.
Terminal elimination half-life is approximately 3-6 hours in adults, but may be prolonged to 15-20 hours in severe hepatic impairment (Child-Pugh class C).
Primarily hepatic metabolism (~95%) via CYP1A2, CYP2D6, and CYP3A4; less than 10% excreted unchanged in urine. Fecal excretion accounts for ~20% of metabolites.
Approximately 5% of ondansetron is excreted unchanged in urine; the remainder is extensively metabolized, with metabolites excreted in urine (46-60%) and feces (22-29%).
Category C
Category C
Antiemetic (5-HT3 Antagonist)
Antiemetic (5-HT3 Antagonist)